Finished product reference
Menthol Salicylate
Ointment · Topical · 10 %/15 % · 30 g
- List code
- 807
- Pharmacologic class
- Topical counter-irritant analgesic (menthol with methyl salicylate)
What it is and how it works
Menthol activates cold-sensitive TRPM8 receptors, producing a cooling sensation and counter-irritant analgesia. Methyl salicylate is a rubefacient that is partly absorbed through the skin and hydrolysed to salicylate, providing local counter-irritant and mild anti-inflammatory effects.
Indications
Symptomatic relief of minor muscular and joint pain, such as backache, strains, sprains, stiffness and minor arthritic pain.
Dosage and administration (summary)
Apply a thin layer to the affected area and rub in gently, up to 3–4 times daily.
Contraindications
Hypersensitivity to salicylates (including aspirin) or menthol; application to broken, irritated or inflamed skin, mucous membranes or near the eyes.
Warnings and precautions
Do not use with heating pads or occlusive dressings or immediately after hot baths, as severe skin irritation or burns may occur. Extensive or prolonged use may lead to systemic salicylate absorption and can potentiate warfarin, increasing INR. Keep out of reach of children; methyl salicylate is highly toxic if ingested.
Pregnancy
Avoid extensive or prolonged use in pregnancy, particularly in the third trimester, because of the salicylate component.
Storage and supply
Store below 25 °C in a tightly closed container.
Source: reference summary prepared from the EU SmPC/EPAR, BNF and WHO Model Formulary. The approved product information in Iran governs.
Reference information for professional sourcing and registration enquiries, not medical advice or a promotion. Drug information is condensed from US FDA prescribing information (public domain, via openFDA and DailyMed) and does not replace the product’s approved labelling in Iran. Availability, origin and documentation are confirmed per enquiry.
Tell us the quantity, the market and the timing.
Send the molecule or ingredient, the specification and the destination. We reply from Tehran with the questions, the documents and the next step.